Natco Pharma Ltd.

Natco Pharma is currently trading at Rs. 784.45, up by 5.35 points or 0.69% from its previous closing of Rs. 779.10 on the BSE.

The scrip opened at Rs. 780.00 and has touched a high and low of Rs. 784.45 and Rs. 775.00 respectively.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 826.00 on 14-Nov-2013 and a 52 week low of Rs. 390.00 on 16-May-2013.

Last one week high and low of the scrip stood at Rs. 826.00 and Rs. 756.00 respectively. The current market cap of the company is Rs. 2,461.00 crore.

The promoters holding in the company stood at 56.61% while Institutions and Non-Institutions held 19.43% and 23.96% respectively.

The company has reported 20.19% rise in its net profit at Rs 28.69 crore for the second quarter ended September 30, 2013 as compared to Rs 23.87 crore for the same quarter in the previous year. However, total income from operation of the company has decreased by 1.28% at Rs 150.06 crore for quarter under review as compared to Rs 152.02 crore for the quarter ended September 30, 2012.

On the consolidated basis, the group has registered a growth of 28.25% in net profit after taxes and minority interest of Rs 26.92 crore as compared to Rs 20.99 crore in the same quarter previous year. However, total income from operation of the group has decreased by 0.61% to Rs 179.22 crore for quarter under review as against Rs 180.32 crore in corresponding quarter previous year.